Aleksandra Rizo - May 15, 2024 Form 3 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
Director
Signature
/s/ Michael A. Metzger, Attorney-in-Fact
Stock symbol
SNDX
Transactions as of
May 15, 2024
Transactions value $
$0
Form type
3
Date filed
5/16/2024, 04:03 PM
Previous filing
Feb 18, 2022

No securities are beneficially owned.